Accretion Pharmaceuticals Limited (NSE:ACCPL)
India · Delayed Price · Currency is INR 203.30
-1.70 (-0.83%)
At close: Sep 25, 2026
Accretion Pharmaceuticals Market Cap
Accretion Pharmaceuticals has a market cap or net worth of 2.26 billion as of September 25, 2026. Its market cap has increased by 234.10% in one year.
Market Cap
2.26B
Enterprise Value
2.34B
Revenue
896.27M
Ranking
n/a
PE Ratio
22.51
Stock Price
203.30
ChartMarket Cap Chart
Since May 21, 2025, Accretion Pharmaceuticals's market cap has increased from 922.07M to 2.26B, an increase of 145.09%. That is a compound annual growth rate of 94.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 2.26B | 131.42% |
| Dec 31, 2025 | 976.54M | 5.91% |
| May 21, 2025 | 922.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BDH Industries | 2.85B |
| Sat Kartar Life | 2.83B |
| Medico Remedies | 2.71B |
| Bilcare | 2.62B |
| Gennex Laboratories | 2.47B |
| Everest Organics | 2.33B |
| Bio Medica Laboratories | 2.12B |
| Sanjivani Paranteral | 2.11B |